Delivery Order SPE2DB22D2211-SPE2DB25FSCSU
Award Date 8/12/25
Potential Completion Date 8/13/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) at a ceiling value of $1,665.22. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,533.96 delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100 count) on August 26, 2025, with completion scheduled for August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. The award represents a child delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,111.08 to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (quantity 100) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,892.67 to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100-count units) under a firm fixed-price contract. The award was issued on March 11, 2025, with an ultimate completion date of March 12, 2025, and represents a non-set-aside competitive award. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100 count) valued at $1,017.86 with a firm fixed price structure. The award was made on September 8, 2025, with an ultimate completion date of September 9, 2025, and no set-aside designation was applied, indicating the contract was competitively awarded. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $2,354.62. This is a non-set-aside competitive award with an ultimate completion date of August 25, 2025, and performance will be executed from the awardee's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,594.20 to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100 count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.999 billion through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,585.84 to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100 count) on August 27, 2025, with a completion date of August 28, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $2,468.26 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, with performance completion targeted for July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a contract value of $2,971.21. This competitively awarded, firm fixed-price delivery order is set to be completed by September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...